1. Lilly to test COVID-19 antibody drug in unorthodox nursing home study — Prepare for an influx of cell and gene therapy approvals — Regeneron pairs with BioNTech on melanoma immunotherapy — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Novartis vaccines predictions

Discussion in 'Vaccines' started by Anonymous, Jan 5, 2009 at 10:58 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What do you think will happen with Novartis vaccines this year and next? Field of fortune or mire of madness?
     

  2. Anonymous

    Anonymous Guest

    Although too difficult to predict, the Sr. Management team is now 100% changed over. The former CEO (Jorge R.), is now back at pharma (COO with Vasella), and their Vaccines President (Rajiv D), left for another company (Raleant Pharma) on Jan 5th. It doesn't seem like things are that great or you would see more stability at top. Time will tell.
     
  3. Anonymous

    Anonymous Guest

    I interviewed in Dallas with an Indian who kept talking about "waccines." That's right, vaccine with a dubya. He was bizarre as shit and I left Dallas knowing I wanted no part of that gig. I vas wery, wery happy not to be called back.
     
  4. Anonymous

    Anonymous Guest

    The drug has been delayed. It will be a long while now if or when it comes to market. Novartis at it's finest again.
     
  5. Anonymous

    Anonymous Guest

    IV's are going strong now, sales force to be hired on by early april!
     
  6. Anonymous

    Anonymous Guest

    BEWARE of CCI!
     
  7. Anonymous

    Anonymous Guest

    CCI...please I am from Merck, I know what it's like!
     
  8. Anonymous

    Anonymous Guest

    Think again. Novartis has taken this to a whole new level. They are trying to and actually succeeding in making this company the worst to work for. There will be some similiarities to the Merck CDM, but I'm telling you to beware.
     
  9. Anonymous

    Anonymous Guest

    What is the starting base for a vaccine rep with 8 years pharm exp? thanks
     
  10. Anonymous

    Anonymous Guest

    Novartis will do well if they do not follow Merck's lead with vaccines.
     
  11. Anonymous

    Anonymous Guest

    total cluster fuck. sanofi has already gobbled up the low hanging fruit in the meningococcal market and Menveo is going to be 2nd to market trying to grab only the incoming 11 year old cohort. good luck with that. If their shitty flu vaccine is any indication, they're screwed. They are consistently unable to sell all their flu doses despite slashing prices to ridiculous levels. Amateur hour.
     
  12. Anonymous

    Anonymous Guest

    Novartis and Glaxo reps/employees should be the first to take the swine flu vaccine, that way we will be sure of the side effects of an untested vaccine.
     
  13. Anonymous

    Anonymous Guest

    Any updates out there on how the new upper management is doing? Trying to figure out if this is a company I should consider (assuming they get some products). Don't know about leadership, other than Merck, etc. sales management.
     
  14. DLD

    DLD Guest



    Listen Asshole. We will kick Menactra's ass......and Dr. M for that matter. Wait til the end of 2011....>50 % market share nationally!!! I will personally see to it. We have a superior product and we are gaining county by county. Game ON........
     
  15. Anonymous

    Anonymous Guest

    Public health will never use this product because you have to reconstitute it. They want something that can be given very quickly at large immunization clinics or school based clinics. Trying to suck every last drop out of Menveo isn't going to cut it. Your best chance is in the private sector with price.....that is it! If you can sell that to a public health nurse, you can sell anything and should get out of the industry to make more $$$$
     
  16. Anonymous

    Anonymous Guest

    It is the end of April and still no luck for Novartis. Why are people starting to leave and the managers look like they are suffering from heart and stomach problems?
     
  17. Anonymous

    Anonymous Guest

    Post #15 explains it all.....